The Personalized Medicine Foundation and CancerConnect are pleased to provide patients and caregivers the opportunity to ask questions about the management of liver and bile duct cancers including cholangiocarcinoma. 

Dr. Tanios Bekaii-Saab, MD FACP is the Professor of Gastrointestinal Cancer Mayo Clinic College of Medicine and Science.


Tanios Bekaii-Saab, MD FACP Professor of Gastrointestinal Cancer Mayo Clinic College of Medicine and Science

Click here to submit your question to Dr. Bekaii-Saab.

Is there a standard initial treatment for stage IV Cholangiocarcinoma? 

Gemcitabine Cisplatin is currently the standard of care . Its also important to get NGS testing performed. - learn more about Cholangiocarcinoma here

Should I get NGS testing if i have a liver cancer?

The short answer is yes. The role of many of the more effective precision cancer medicines is determined by NGS testing in liver cancer. Less common cancers like cholangiocarcinoma can also be more effectively treated if a biomarker can be defined that has an available precision medicine. 

Recommended Articles


Mobocertinib Treatment for Non-Small Cell Lung Cancer with exon 20 Mutations

FDA grants breakthrough therapy status to Mobocertinib for treatment of patients with NSCLC and exon 20 mutations.

Image placeholder title

Tagrisso® - Standard of Care for EGFR + Non Small Cell Lung Cancer

FLAURA study confirms Tagrisso as best initial treatment of EGFR + NSCLC - learn more about its role in NSCLC management

The Ask The Expert Series is made possible by support from The Personalized Medicine Foundation, Incyte Oncology, Abbvie, and CancerConnect. The "Ask The Expert" series is not medical advice nor is it a substitute for your doctor. It should serve as a guide to facilitate access to additional information and enhancement of a shared decision making process with your treating physician.